Accumulating clinical and experimental evidence indicates that mesenchymal stem cells (MSCs) 
Introduction

Heart disease remains the number one killer in developed countries and often leads to damage or loss of functional heart tissue. Cell therapy may provide an effective intervention for repair of cardiac injury due to the self-renewing and multipotential nature of specific cells. Mesenchymal stem cells (MSCs) contain a population of cells that are self-renewing, and are capable of differentiating into
factors, so that growth factors and cytokines are locally produced [2] . They [3, 4] . [6, 7] [8] .
MSC isolation, characterization and standardization
The term 'mesenchymal stem cell' is commonly applied to plasticadherent cell preparations isolated from bone marrow or other tissues that are positive for a typical panel of MSC surface markers, and that are able to differentiate into different cell types under specific in vitro or in vivo differentiating conditions
Their relatively simple but at the same time quite unspecific isolation method notoriously leads to certain heterogeneity of the isolated cells. In any case it is commonly accepted that preparations comprise a multipotent adult stem cell population, which is able to differentiate into different mesodermal cell lineages including osteoblasts, chondroblasts, adipocytes and myocytes. On the other hand, their heterogeneity is reflected by the different cellular morphologies and clonal growth patterns of the initial colonies formed [5]. Strictly speaking, MSCs do not fulfil the criteria of 'stem cells', because of the heterogeneous composition and subpopulations coupled with limited evidence for self-renewal capacity. Therefore, these cell preparations have alternatively been named 'mesenchymal stromal cells', 'multipotent mesenchymal stromal cells', 'multipotent stromal cells' or 'mesenchymal progenitor cell'
. The rich nomenclature for MSCs would not be problematic, if all the different names would basically refer to the same type of cell preparation. Then we would be using many alternative names for the same type of plastic-adherent cell preparation. However, the multitude of different protocols for the isolation of MSCs and the discrepancies of the results reported from different laboratories clearly implies that the nonstandardized isolation methods have also led to tremendous functional differences between these cell preparations and that we are literally comparing 'apples and oranges'
Isolation from different sources
MSCs were originally isolated from bone marrow [9, 1] , but similar populations have been reported in adipose tissue [10] , umbilical cord blood [11] , peripheral blood [12] , connective tissues of the dermis and skeletal muscle [13] . A recent finding suggested human multipotent adult stem cells can be generated from heart and liver [14] . Furthermore, the criteria currently used for definition of MSCs are also met by cells isolated from other tissues of adult mice such as brain, liver, kidney, lung, thymus and pancreas [15] . Despite the fact that almost every organ seems to contain MSCs, the precise identity of the counterpart of the MSCs in vitro isolates in vivo in the adult remains elusive, although increasing data suggest that MSCs reside within the perivascular zone [16, 17] [18] [19] [20] . [33] [34] [35] . ICLCs were identified in various cavitary and noncavitary human organs [36, 37] as well as in blood vessels [38, 39] Fig. 1) [41] . Makino [42] and Toma [43] reported that after treatment with [49] . When injected into an early blastocyst, a single MAPC could contribute to the development of various tissues [22] . However, the experimental procedure seems to be very difficult to reproduce [50, 51] . It has been speculated that MAPCs might represent an extremely small subpopulation of cells that must be selected and maintained under very strict conditions for many passages before they can be established [13, 52] [54, 55] . In this context the expression and secretion of HLA-G molecules by MSCs is of significant importance in the down-regulation of T-cell alloreactivity [56] .
Isolation under different culture conditions
Characterization of MSCs
Standardization of MSCs
Mechanisms of cardiac repair
Differentiation of MSCs towards cardiomyocytes
MSCs exhibit an enormous in vitro expansion capacity and more importantly a broad differentiation potential into not only mesodermal (including osteoblasts, adipocytes and chondrocytes), but also, albeit still controversial, endodermal (hepatocyte-like cells) and ectodermal lineages (neuronal, neuroglial cells) (
5-azacytidine rat MSCs differentiated into cardiomyocyte lineages both in vivo and in vitro. Myogenic differentiation of rat MSCs was also detected in vitro after treatment with bone morphogenetic protein (BMP)-2 and fibroblast growth factor (FGF)-4 [44]. MSCs were able to develop into cardiomyocyte-like cells, which expressed the cardiac myocyte markers myosin heavy chain and troponin T in cardiomyocyte medium subjected to hypoxia re-oxygenation [45]. If prolonged treatment with hepatocyte growth factor (HGF) was performed, the expression of cardiac-specific markers such as GATA-4, ␣-and ␤-myosin heavy chain and others was reported [46]. Li et al. reported a localization of troponin T in 4'6-diamidino-2-phenylindoldihydrochloride (DAPI)-labelled B-cell lymphoma (Bcl)-2-transduced MSCs in a rat model of permanent ligation of left anterior descending coronary artery [47] indicating a differentiation towards cardiomyocyte-like cells. Despite these promising initial results, the in vitro and in vivo cardiac differentiation of MSCs has been recently re-evaluated. Only a small proportion (~0.07%) of bone marrow
Mesenchymal stem cells and blood vessel regeneration
Large body of evidence indicates that MSCs could stabilize blood vessel formation and enhance angiogenesis after cardiac injury [57] [58] [59] both in in vitro and in in vivo models [60, 61] [15] . A perivascular niche of postnatal MSCs in human bone marrow, dental pulp and thoracic aortas was found [62] [74] . Increased expression of integrin subunits ␣1, ␣5, ␣7, ␤1/␤1D has been described upon chronic pressure loading in mice [75] . [78] . Integrin subunits ␣1, ␣2, ␣3, ␣v, ␤1, ␤3 and ␤4 have been described in human MSCs [1] . [80] so targeted delivery should be possible.
. There is a close association between MSCs and vasculature. It is reported MSCs reside in virtually all postnatal organs and tissues. MSC-like cultures from blood vessels alone could be established in vitro
Dystroglycan complex
CXCL12, and alarmins (danger-associated molecular patterns released from necrotic and/or activated cells). This activates and up-regulates the MSC integrin receptors
The process then continues, perhaps mainly via firm Int ␣4␤1-dependent binding to endothelial vascular cell adhesion molecule (VCAM)-1 [77], followed by transmigration into tissue. In the tissues the interstitial MSCs meet other sets of matrix molecules as outline above, which guide them further, which have been much less studied. The relatively poor engraftment in the injured heart after i.v. infusion of MSCs suggests that the cells to be transplanted should be 'tailored' in vitro, perhaps by appropriate isolation, expansion or pre-treatment procedure (see below under section 'Dehydroepiandrosterone' [DHEA]), for an appropriate set of adhesion molecules, in particular the integrins. Using modern high throughput technologies [79], it has been shown that all organ and tissue sites have their vascular 'zip codes'
Ex vivo manipulation of MSCs Pre-treatment of MSCs with growth factors
There are different approaches for MSC manipulation (Fig. 4) [45] , possibly preventing earlier reported adverse effects, such as osteogenesis [94] . [95] . Fig. 2 .
. The low cellular survival rate and transdifferentiation potency of MSCs after cardiac transplantation engenders only marginal functional improvement by directed recruitment and replacement of lost myocardiocyte cell mass [43, 81]. Thus, interventions that would facilitate differentiation and enhance the cytoprotective effects of MSCs could form a rational approach against the arduous microenvironment incurred from ischaemia, inflammatory response. To improve efficacy of MSC transplantation, the role of growth and differentiation factors to expand the stem cells and to facilitate their engraftment into cardiac tissue has been recently studied, including FGF-2, insulin-like growth factor (IGF)-1 and BMP-2 [82-85]. Combination of these growth factors might greatly facilitate differentiation of MSCs into cardiomyocytes. Furthermore, an antiapoptotic signal was delivered by many growth factors, and the expression of connexin-43 was increased [86]. Pre-treatment of
Fig. 2 Intracrine processing of serum dehydroepiandrosterone sulphate (DHEA-S). In the circulation the concentration of DHEA-S is more than 200-fold higher than that of DHEA as it serves as the DHEA reservoir. DHEA-S is taken up by cells via organic anion transporter protein-B. Inside the cell it can be desulphated by steroid sulphatase, but resulphated by sulphotransferase. Free DHEA is fed into the further intracrine machinery, some key enzymes of which are shown in the figure and include 3␤-hydroxysteroid dehydrogenases (3␤-HSD), 17␤-hydroxysteroid dehydrogenases (17␤-HSD), aromatase and 5␣-reductase. This intracrine machinery has been apparently fine-tuned in different cells and tissues to meet the local needs; such tailor making does not occur in murines, and these murine models cannot be therefore not be used to study intracrine processing of DHEA.
MSCs with growth factors might enhance transfer of anti-apoptotic signal to CMCs.
Genetic engineering
expression of c-Met is induced and c-Met signalling is enhanced, resulting in higher migration rates in response to ischaemic tissue-secreted HGF after intraarterial injection in a rat hind limb ischaemia model [93]. These data suggest a specific influence of hypoxia on MSCs that in the case of Aktactivation leads to a better survival of anoikisis, cell death by integrin detachment, which can threaten the desired outcome of the cell transplantation processes. Li et al. showed significant hypoxiainduced VEGF-overexpression and enhanced MSC survival rate under hypoxia after Bcl-2 (B-cell lypmphoma)-gene transfer in rat MSCs in vitro. It was concluded, that there is a hypoxia-regulated, VEGF-mediated cardioprotective effect and the induction of functional collateral vessels when Bcl-2-engineered MSCs are transplanted into infarcted hearts [47]. Apart from beneficial effects on cell metabolism hypoxic preconditioning can direct cells to cardiogenic differentiation prior to transplantation
Pharmacological interventions Dehydroepiandrosterone pro-hormone It has been well established and recently reviewed that sexual dimorphism exists in many cardiovascular, cardiopulmonary, neurodegenerative and endocrine disorders. Oestrogen stimulates growth hormone production by bone marrow MSCs and endothelial progenitor cells (EPCs), and apparently via stimulation of somatomedin C (IGF-I) influences myocardial remodelling after an ischaemic insult. Other useful effects include oestrogen-stimulated angiogenesis and oestrogen-inhibited cardiac fibrosis. It is concluded that '…a greater understanding of sex hormones on diverse stem cell populations is required to improve their ultimate clinical efficacy'
Although MSCs are affected by sex steroids, little attention has been paid to two interesting facts: (1) serum DHEA levels are very high at the time of birth and rapid growth and development; (2) DHEA, normally produced in zona reticularis of the adrenal cortex is, in man and higher apes, subjected to organ-specific, intracrine conversion to active sex steroids. Organ-specific refers here to tailor making: in female breast and uterus, most of it is converted to 17␤-oestradiol, whereas in male prostate most become dihydrotestosterone. It is similarly but as yet unknown way converted to active sex steroids in other organs along the intracrine pathways shown in
It has been estimated that 75% of the oestrogens in premenopausal and 100% of the oestrogens in post-menopausal women derives from DHEA. Similarly, 50% of testosterone is locally produced from DHEA even in younger men [96] . Sex steroids can have important regulatory effects. It was recently shown that DHEA treatment up-regulates 5-20-fold integrin ␣1 and ␣2 subunits, which enables the intercalated duct epithelial progenitory cells in salivary glands to migrate to acinus, and to receive there a differentiation signal from The basement-membrane located laminin ␣1 [97] so that they transdifferentiate into secretory acinar cells [98] . Interestingly, oestrogens have been shown to affect mouse bone marrow MSCs, but there have been no studies on the eventual intracrine DHEA processing machinery in these cells although ongoing studies demonstrate that some such enzymes are present and some are induced by the presence of substrate in a positive feedforward feedback system (Fig. 2) . Studies are ongoing on the effect of such treatment on their integrin receptor expression levels. [107] to significant [109] [110] [111] . In cardiomyopathy beneficial effects on cardiac function were reported [112, 113] . [115] . In another study of EAM in rat an inhibited myocardial expression of the inflammatory cytokines interleukin-2, -6, and -10 mRNAs was found [116] . It was also suggested that MSCs are suitable to prevent chronic rejection in heart transplantation due to CD4 ϩ T-cell suppression [117] . Migration of intravenously transferred MSCs to heart allograft during chronic rejection was reported [118] . However, also reports of eventual promotion of rejection were made [119] . [47, 53] .
Atorvastatin
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-
